There is an ongoing need for development of new chemotherapeutic regimens for metastatic breast cancer [mBC]. especially when tumors lack therapeutic targets such as the estrogen or progesterone receptor [ER/PR]. or the human epidermal growth factor receptor-2 [HER2]. Capecitabine is an orally bioavailable fluoropyrimidine approved for monotherapy in mBC. https://www.diegojavierfares.com/flash-pick-Plancha-de-vapor-vertical-Rowenta-Access-Steam-Force-DR8270D1-90-g-min-200-ml-Negro-y-plateado-super-save/